glp-1 news nov 2025 Agonists Weight Loss Drugs Market Report, 2025-2030 Understanding GLP-1s and their dynamic
Description
Heres why it might be your next step toward achieving your health goals
1. Semaglutide (GLP-1)
A third Novo Nordisk drug containing semaglutide, Rybelsus, is prescribed to treat type 2 diabetes but is also commonly used for weight loss
Rita Kathawa, MD Dr
& Petrovich, G
A real-world study suggested that over a 5-year period, GLP-1RAs were associated with a reduced risk of prostate, lung and colon cancer compared with metformin, but might be linked to an elevated risk of thyroid cancer (203)
